NCT00535405
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
See it on ClinicalTrials.gov ↗1,289 people
62.8%
37.2%
809 womenmiddle line = equal numbers480 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2009-03
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 65 Years – no maximum
- Average age
- mean 72.0 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 83.9% · Other 10.5% · Asian 3.6% · Black / African American 2.1%
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.